| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142265 Compositions comprising multiple bioactive agents, and methods of using the same |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142243 Promoting repair of skin and mucous membrane tissues, the product of the present invention exhibits unique effects for controlling inflammation, damage, infection, and exudation; side effect reduction; topical administration |
| 06/29/2006 | US20060142240 Using isoguanosine nucleoside analogs, and derivatives thereof, in cell cultures and in antiviral therapy; increasing the mutation rate of a virus such as bovine viral diarrhea virus and hepatitis C virus |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142217 Bactericides for antibiotic-resistant Micrococcus, Streptococcus, Enterococcus or Staphylococcus; pure saccharide antibiotics; 4-((3-(trifluoromethyl-)phenyl)-amino-carbonylamino-),4,5-(dihydroxy-),6-(hydroxymethyl-)tetrahydropyran-2-yl)-),5-(undecanoylamino-),6-(hydroxymethyl-)tetrahydropyran |
| 06/29/2006 | US20060142206 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 06/29/2006 | US20060142204 Pyrrolidine derivatives for use in treating heaptitis c virus infection |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142183 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060141013 Lysine mixture and apparatus and method for administering lysine |
| 06/29/2006 | US20060140981 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 06/29/2006 | US20060140979 Antigenic polypeptides |
| 06/29/2006 | US20060140976 Trivalent vaccine with material antibody transfer via the milk |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140931 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140911 Bacteriophage for the treatment of bacterial biofilms |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | DE102004061503A1 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases |
| 06/29/2006 | CA2634499A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
| 06/29/2006 | CA2594602A1 8-aza-bicyclo (3.2.1) octane derivatives with an activity on chemokine ccr5 receptors |
| 06/29/2006 | CA2592388A1 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 06/29/2006 | CA2592156A1 Vaccines against neisseria meningitidis |
| 06/29/2006 | CA2592099A1 Conserved hbv and hcv sequences useful for gene silencing |
| 06/29/2006 | CA2592005A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/29/2006 | CA2591746A1 Macrolides |
| 06/29/2006 | CA2591665A1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/29/2006 | CA2589748A1 Heterocyclic compounds as ccr2b antagonists |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674112A1 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 06/28/2006 | EP1674104A1 Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV |
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1673449A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 06/28/2006 | EP1673448A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 06/28/2006 | EP1673447A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 06/28/2006 | EP1673385A1 Macrocyclic peptides active against the hepatitis c virus |
| 06/28/2006 | EP1673371A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/28/2006 | EP1673081A1 Indoles and azaindoles as antiviral agents |
| 06/28/2006 | EP1673080A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1554276B1 Non-nucleoside reverse transcriptase inhibitors |
| 06/28/2006 | EP1409034B1 Topical pharmaceutical formulation |
| 06/28/2006 | EP1341758B1 Coniosetin and derivatives thereof, method for producing the same and use thereof |
| 06/28/2006 | EP1280500B1 Synergistic antiplaque/antigingivitis oral composition |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1255561B1 Proteosome influenza vaccine |
| 06/28/2006 | EP1218031B1 Pharmaceutical composition comprising an antigen |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1061922B1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 06/28/2006 | EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 06/28/2006 | EP0951281B1 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 06/28/2006 | EP0757722B1 HERPES VIRUS TRANSFORMED TO EXPRESS gD IN VITRO |
| 06/28/2006 | CN1795191A 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 06/28/2006 | CN1795000A Compositions containing lactulose for treating potavirus infections |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794974A 药物递送体系 Drug delivery system |
| 06/28/2006 | CN1794915A Aqueous compositions for disinfection and/or sterilization |
| 06/28/2006 | CN1793170A Polypeptide of inhibiting HIV virus fusion and application thereof |
| 06/28/2006 | CN1793155A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 06/28/2006 | CN1793154A 3,5-di-0-(4-chlorobenzoyl)-2-deoxide-D-erythro-furan glucoside and preparation process thereof |
| 06/28/2006 | CN1793145A 7-bit substituted comptothecine kind compound and pharmaceutical use thereof |
| 06/28/2006 | CN1793134A Process for separating purifying actived tea polyphenols |
| 06/28/2006 | CN1793132A Derivative of cyclo membranousol kind and application thereof |
| 06/28/2006 | CN1793128A Anti anaerbic bacterial compound |
| 06/28/2006 | CN1793120A Thiourea kind compund with inhibiting virus capsid protain activity and its preparation process and application thereof |
| 06/28/2006 | CN1792364A Medicinal composition contg. stavudine and valproic acid or salts thereof |
| 06/28/2006 | CN1792363A Medicinal composition contg. IDV and valproic acid or salts thereof |
| 06/28/2006 | CN1792362A Abiduoer and its salts prepns. for vena administration, and its preparing method |
| 06/28/2006 | CN1792361A Compound medicine composition for treating hepatitis effectively |
| 06/28/2006 | CN1792286A Cigarette-like smoking substitute for women use |
| 06/28/2006 | CN1261446C Nucleotide specific for escherichia coli 0141 O-antigen |
| 06/28/2006 | CN1261445C Nucleotide specific for escherichia coli 0156 O-antigen |
| 06/28/2006 | CN1261444C Nucleotide specific for escherichia coli 054 O-antigen |
| 06/28/2006 | CN1261439C Cefixime sodium pharmaceutical composition and its preparation and application |
| 06/28/2006 | CN1261436C Bibenzil compound 13,13'-O-iso-propylidene riccardia D and its extraction and separation method and use |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/28/2006 | CN1261161C Compound interferon inducing agent lozenge |
| 06/28/2006 | CN1261160C Hybrid yeast AIDS vaccine |
| 06/28/2006 | CN1261157C Pharmaceutical composition with liver cell protecting function |
| 06/28/2006 | CN1261152C Chinese medicine for treating Hepatopathy |
| 06/28/2006 | CN1261143C Separating preparation process of effective part and active component of influenza virus resisting medicine |
| 06/28/2006 | CN1261139C Medicine for treating bone tuberculosis, osteomyelitis, synovitis and angiitis |